- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
VSTM Market Currents
more »
Currently, there are no Market Currents on VSTM.
VSTM in Focus
more »
VSTM Related Articles
more »
VSTM News
more »
-
at MarketWatch.com (Feb 2, 2012)
-
at MarketWatch.com (Jan 30, 2012)
VSTM Press Releases and Filings
more »
-
Business Wire (Mon, 4:00PM)
-
Business Wire (May 14, 2012)
-
Business Wire (Apr 26, 2012)
-
Business Wire (Apr 12, 2012)
-
Business Wire (Apr 9, 2012)
VSTM Latest Transcript
more »
Currently, there are no transcripts for VSTM.
VSTM Cramer
more »
Currently, there are no Cramer articles on VSTM.
VSTM Instablog posts
more »
Currently, there are no Instablog posts on VSTM.
VSTM vs. ETF Alternatives
Company Description
We are a biopharmaceutical company focused on discovering and developing proprietary small molecule drugs targeting cancer stem cells in breast and other cancers along with proprietary companion diagnostics. A cancer stem cell is a particularly aggressive type of tumor cell, resistant to... More
